Prolongation of the QTc interval in African children treated for falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 56, Issue 5, 1997, Pages 494-497

  Von Seidlein, Lorenz ^a   Jaffar, Shabbar ^a   Greenwood, Brian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL; CHLOROQUINE; FANSIDAR; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FEVER; GAMBIA; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PARASITEMIA; QT INTERVAL; RELAPSE;

EID: 0030905911     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.56.494     Document Type: Article

References (24)

1. White NJ, Looareesuwan S, Warrell DA, 1983. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Card Pharm 5: 173-175.
2. Nosten F, Ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ, 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341: 1054-1056.
3. Castot A, Rapoport P, Le Coz P, Monlun E, Pillet J, Cochard JF, Le Bras M, 1993. Prolonged CT interval with halofantrine. Lancet 341: 1541-1542.
4. Monlun E, LeMetayer P, Szewandt S, Neau D, Longy-Boursier M, Horton J, Le Bras M, 1995. Cardiac complications of halofantrine: a prospective study of 20 patients. Trans R Soc Trop Med Hyg 89: 430-433.
5. Toivonen L, Viitasalo M, Siikamaki H, Raatikka M, Pohjola-Sintonen S, 1994. Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome. Clin Cardiol 17: 403-404.
6. Karbwang J, Na Bangchang K, Bunnang D, Hannasuta T, Laothavorn P, 1993. Cardiac affect of halofantrine. Lancet 342: 501.
7. Fourcade L, Hovette P, De Pina J, Rault JP, Peyron F, Touze JE, 1995. Prolonged QT interval and cardiac toxicity due to halofantrine. Med Trop (Mars) 55: 182-183.
8. Touze JE, Bernard J, Keudjian A, Imbert P, Viguier A, Chaudet H, Doury JC, 1996. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg 54: 225-228.
9. Matson PA, Luby SP, Redd SC, Rolka HR, Meriwether RA, 1996. Cardiac effects of standard dose halofantrine therapy. Am J Trop Med Hyg 54: 229-231.
10. Hien T, Day N, Phu N, Mai N, Chau T, Loc P, Sinh D, Chuong L, Vinh H, Waller D, Peto T, White N, 1996. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335: 76-83.
11. Looareesuwan S, White N, Chanthavanich P, Edwards G, Nicholl D, Bunch C, Warrell DA, 1986. Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br J Clin Pharmacol 22: 31-36.
12. Bazett HC, 1920. An analysis of time relations of electrocardiograms. Heart 7: 353-370.
13. Park MK, Guntheroth WG, 1992. How to Read Pediatric EGCs. St. Louis: Mosby Year Book.
14. Bryk AS, Raudenbush SW, 1993. Hierarchical Linear Models: Applications and Data Analysis Methods. Newbury Park, London: Sage Publications.
15. Multilevel Models Project, 1993. A Guide to ML3 for New Users London: Institute of Education.
16. Warrell DA, Molyneux ME, Beales PF, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg (suppl 2): 1-65.
17. Tan H, Hou C, Lauer M, Sung R, 1995. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 122: 701-714.
18. Sheldon R, Duff H, Koshman ML, 1995. Antiarrhythmic activity of quinine in humans. Circulation 92: 2944-2950.
19. Karbwang J, Thanavibul A, Molunto P, Na-Bangchang K, 1993. The pharmacokinetics of quinine in patients with hepatitis. Br J Clin Pharmacol 35: 444-446.
20. Karbwang J, Davis TM, Looareesuwan S, Molunto P, Bunnag D, White N, 1993. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 35: 265-271.
21. Bhavnani SM, Preston SL, 1995. Monitoring of intravenous quinidine infusion in the treatment of Plasmodium falciparum malaria. Ann Pharmacother 29: 33-35.
22. Watt G, Na Nakorn A, Bateman DN, Plubha N, Mothanaprakoon P, Edstein M, Webster HK, 1993. Amplification of quinine cardiac effects by the resistance reversing agent prochlorperazine in falciparum malaria. Am J Trop Med Hyg 49: 645-649.
23. Bustos M, Gay F, Diquet B, Thomare P, Warot D, 1994. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop Med Parasitol 45: 83-86.
24. Laothavorn P, Karbwang J, Na Bangchang K, Bunnang D, Harinasuta T, 1992. Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients. Southeast Asian J Med Trop Public Health 23: 51-54.